Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Aditya Birla SL Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited17.7853401896.4073
Domestic EquitiesCipla Limited8.9508214503.2246
Domestic EquitiesMax Healthcare Institute Limited8.7715283483.1600
Domestic EquitiesApollo Hospitals Enterprise Limited7.921838522.8539
Domestic EquitiesDr. Reddys Laboratories Limited7.8915232332.8430
Domestic EquitiesDivi's Laboratories Limited7.648448432.7554
Domestic EquitiesFortis Healthcare Limited5.3498198731.9273
Domestic EquitiesLupin Limited4.894892261.7634
Domestic EquitiesTorrent Pharmaceuticals Limited3.988839881.4370
Domestic EquitiesLaurus Labs Limited3.4620148161.2472
Domestic EquitiesAlkem Laboratories Limited3.231621461.1642
Domestic EquitiesAurobindo Pharma Limited3.2088106651.1560
Domestic EquitiesGlenmark Pharmaceuticals Limited3.112257421.1212
Domestic EquitiesMankind Pharma Ltd2.914643111.0500
Domestic EquitiesZydus Lifesciences Limited2.596295250.9353
Domestic EquitiesBiocon Limited2.1682229050.7811
Domestic EquitiesIPCA Laboratories Limited1.969452990.7095
Domestic EquitiesAbbott India Limited1.61801990.5829
Domestic EquitiesSyngene International Limited1.250572330.4505
Domestic EquitiesPiramal Pharma Ltd1.2505235670.4505
Total 99.9845 36.0203
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Limited0.9160 0.3300
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.9005 -0.3244
Total 0.0155 0.0056
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.